Story preview
Topics in this story
Continue reading on the publisher site for the full article.
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Outlets covering it
6
in the last 3 days
First reported
4 days ago
5 outlets since
Countries
5 other outlets reported this story in the last 3 days.
Tesla stock remains one of Wall Street's hottest debates. Experts reveal the risks, growth drivers and AI bets investors should watch closely.
European markets were hit by a string of strong inflation readings
Amgen faced intraday downward pressure and profit-taking after rallying to multi-year highs.Core commercial volume growth remained strong alongside ongoing headwinds from biosimilar competition.Technical indicators show a neutral MACD of 5.033 and an RSI of 50.194.